Some fish swim in synchrony. Others, it turns out, breathe in synchrony. This is true for Arapaimas, an obligate air-breathing species living in the Amazon. A new study in Communications Biology, led by the Leibniz Institute of Freshwater Ecology and Inland Fisheries (IGB) in collaboration with the Cluster of Excellence “Science of Intelligence”, has demonstrated for the first time that arapaima juveniles gather by the hundreds to synchronize their trips to the water surface with split-second precision, most likely to avoid predators and maximize survival and efficiency. The principle behind this behavior could also help inform mathematical models for synchronizing heterogeneous groups of robots or drone swarms.

A research team from the Chinese Academy of Sciences proposed PLSaoNET, a general method that provides neural networks a statistically meaningful start and clear training path, replacing blind random initialization. It lowers the application barrier for small-sample, high-noise industrial scenarios and fundamentally enhances the reliability of data-driven modeling.

CAMBRIDGE, Mass. / HONG KONG — June 17, 2026 — Insilico Medicine (“Insilico”, HKEX: 3696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced it has achieved the first clinical milestone in its co-development collaboration with Hygtia Therapeutics with the completion of first-in-human dosing in the Phase I study of ISM8969. ISM8969 is a potentially best-in-class, orally available, brain-penetrant small-molecule inhibitor of the NLRP3 inflammasome being developed to treat chronic neuroinflammation and central nervous system (CNS) disorders, including Parkinson’s disease.

Neurosurgeons at University of Michigan Health completed the first-in-human implant of a Paradromics Inc., wireless brain-computer interface, or BCI, as part of a national clinical trial for patients with difficulty speaking. The clinical trial will focus on the device’s long-term safety, and it will also assess whether the BCI can restore the participant’s communication through synthesized text and speech, and help them control a computer.

Neurosurgeons at University of Michigan Health completed the first-in-human implant of a Paradromics Inc., wireless brain-computer interface, or BCI, as part of a national clinical trial for patients with difficulty speaking. The clinical trial will focus on the device’s long-term safety, and it will also assess whether the BCI can restore the participant’s communication through synthesized text and speech, and help them control a computer.

The team built an AI forecasting tool that predicts the likelihood of staff resigning, giving managers an early warning system to intervene before someone leaves